FIELD: medicine.
SUBSTANCE: according to the invention, a matrix tablet contains trimetazidine, polymer of methacrylic acid, wax and adjuvants. Montanic glycolic wax is used preferentially. A core tablets are film coated.
EFFECT: tablet provides prolongation of antiischemic effect to 8 or 12 hours and intake of preparation once or twice a day.
16 cl, 1 dwg, 1 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRIMETAZIDINE PREPARATION AS MATRIX TABLET OF PROLONGED ACTION AND METHOD FOR MAKING THEREOF | 2007 |
|
RU2377989C2 |
| METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
| CRYSTAL STRUCTURE OF MEDICATION IN TABLET FORM (VERSIONS) | 2009 |
|
RU2420286C2 |
| PROLONGED PHARMACEUTICAL COMPOSITION DRUG FORM AND METHOD OF ITS PRODUCTION (VERSIONS) | 2009 |
|
RU2435584C2 |
| AGENT BASED ON DRY MOTHERWORT EXTRACT AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2589507C1 |
| MODIFIED RELEASE DOSAGE FORM OF TRIMETAZIDINE DIHYDROCHLORIDE | 2009 |
|
RU2412706C1 |
| SLOW-RELEASE MATRIX PREPARATION CONTAINING BASE AGENT OR ITS SALT AND METHOD FOR MAKING THEREOF | 2005 |
|
RU2390354C2 |
| METHOD OF TREATING CARDIOVASCULAR DISEASES | 2012 |
|
RU2570752C2 |
| TABLET WITH ENTEROSOLUBLE COATING AND METHOD OF PREPARING | 1998 |
|
RU2201217C2 |
| TWO-LAYER TABLET COMPOSITION | 2020 |
|
RU2824129C2 |
